MAIA Pharmaceuticals Selected by Asahi Kasei Pharma to Advance Teribone™ for US Osteoporosis Patients
PR Newswire —
A proven bone-forming osteoporosis therapy optimized for real-world use and patient compliance PRINCETON, N.J., Feb. 19, 2026 /PRNewswire/ -- MAIA Pharmaceuticals, Inc. today announced a strategic collaboration with Asahi Kasei Pharma Corp., under which MAIA will advance Teribone™...